Tantalum, courtesy of Enough Project via YouTubeThe federal appeals court for the D.C. circuit issued its opinion Monday in National Association of Manufacturers (NAM), et al., v. Securities and Exchange Commission that partially struck down the SEC’s conflict minerals disclosure rule.
Search Results for: label/Stryker – Page 3
The former compliance director of an Indiana compounding pharmacy pleaded guilty Wednesday to introducing adulterated drugs into interstate commerce and then covering up the offenses by obstructing the Food and Drug Administration.
Job Title: Compliance Officer
Company: Bilfinger SE
Location: Mannheim, Germany
The Compliance Officer will lead efforts to promote compliance at all levels of Bilfinger and contribute to the continuous improvement of the compliance program and the underlying elements. She/he will support the business to implement and apply compliance-related policies, controls and procedures. The position holder will report to the Chief Compliance Officer and will be part of the global Compliance Leadership Team.
Shire Pharmaceuticals LLC will pay $56 million to settle allegations that its marketing and promotion of several drugs violated the False Claims Act, the Justice Department said Wednesday.
A former saleswoman for medical device maker Acclarent was awarded $3.5 million as her share of an $18 million settlement of a whistleblower suit alleging false marketing claims.
Chicago-based spirits maker Beam Suntory Inc. agreed Monday to pay more than $8 million to resolve Foreign Corrupt Practices Act charges for improper payments by its Indian subsidiary.